Related references
Note: Only part of the references are listed.Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma
P. Jimenez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: An update on the molecular mechanisms
William Ka Kei Wu et al.
CANCER LETTERS (2010)
Spinal Ceramide Modulates the Development of Morphine Antinociceptive Tolerance via Peroxynitrite-Mediated Nitroxidative Stress and Neuroimmune Activation
Michael M. Ndengele et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Spinal ceramide and neuronal apoptosis in morphine antinociceptive tolerance
Leesa Bryant et al.
NEUROSCIENCE LETTERS (2009)
Cyclooxygenase-2 polymorphisms and the risk of esophageal adeno- or squamous cell carcinoma
Jon O. Kristinsson et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide
Irina Petrache et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells
Shengbao Li et al.
CANCER INVESTIGATION (2008)
Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice
Carolina Muscoli et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Effects of long-term cyclo-oxygenase 2 selective and acid inhibition on Barrett's oesophagus
A. Lanas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Secondary chemoprevention of Barrett's esophagus with celecoxib: Results of a randomized trial
Elisabeth I. Heath et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
The effects of esomeprazole combined with aspirin or rofecoxib on prostaglandin E2 production in patients with Barrett's oesophagus
G Triadafilopoulos et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer
F Cianchi et al.
CLINICAL CANCER RESEARCH (2004)
Biologically active sphingolipids in cancer pathogenesis and treatment
B Ogretmen et al.
NATURE REVIEWS CANCER (2004)
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer
PH Jones et al.
BRITISH JOURNAL OF CANCER (2004)
Modification of insulin-like growth factor 1 receptor, c-Src, and Bcl-XL protein expression during the progression of Barrett's neoplasia
S Iravani et al.
HUMAN PATHOLOGY (2003)
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus
NS Buttar et al.
GASTROENTEROLOGY (2002)
Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer
F Cianchi et al.
GASTROENTEROLOGY (2001)
Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
VN Shirvani et al.
GASTROENTEROLOGY (2000)
Share Paper
